On Friday Teva Pharma (NYSE: TEVA) issued 2013 guidance that disappointed investors, sending shares lower. However, shares later recovered losses ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE